12
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Genetic screening in patients of reproductive age

How do you advise prospective parents who want to know specific risks?

, MD & , MD
Pages 121-135 | Published online: 30 Jun 2015

References

  • Collins FS, Patrinos A, Jordan E, et al. New goals for the US Human Genome Project: 1998–2003. Science 1998; 282(5389): 682–9
  • Caskey CT. Molecular medicine: a spin-off from the helix. JAMA 1993; 269(15): 1986–92
  • Yoon PW, Freeman SB, Sherman SL, et al. Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: a population-based study. Am J Hum Genet 1996; 58(13): 628–33
  • Hecht CA, Hook EB. The imprecision in rates of Down syndrome by 1 -year maternal age intervals: a critical analysis of rates used in biochemical screening. Prenat Diagn 1994; 14(8): 729–38
  • Hook EB, Cross PK, Schreinemachers DM. Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA 1983; 249(15): 2034–8
  • Crow JF. The high spontaneous mutation rate: is it a health risk? Proc Natl Acad Sci USA 1997; 94(16): 8380–6
  • Risch N, Reich EW, Wishnick MM, et al. Spontaneous mutation and parental age in humans. Am J Hum Genet 1987; 41(2): 218–48
  • Kronn D, Jansen V, Ostrer H. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population. Arch Intern Med 1998; 158(7): 777–81
  • Technical advisory: Ashkenazi Jewish carrier test. Genzyme Corporation, 1999
  • Petrou M, Modell B. Prenatal screening for haemoglobin disorders. Prenat Diagn 1995; 15(13): 1275–95
  • Old J. Haemoglobinopathies. Prenat Diagn 1996; 16(3): 1181–6
  • Cohn GM, Cimaroli T, Gould M, et al. The usefulness of a prenatal genetic questionnaire in genetic risk assessment. Obstet Gynecol 1996; 88(5): 806–10
  • Lie RT, Wilcox AJ, Skjaerven R. A population-based study of the risk of recurrence of birth defects. N Engl J Med 1994; 331 (1): 1–4
  • Antonarakis SE. Diagnosis of genetic disorders at the DNA level. N Engl J Med 1989; 320(3): 153–63
  • Sutherland GR, Mulley JC. Fragile X syndrome and fragile XE mental retardation. Prenat Diagn 1996; 16(13): 1199–211
  • Abbs S. Prenatal diagnosis of Duchenne and Becker muscular dystrophy. Prenat Diagn 1996; 16(13): 1187–98
  • Mitchell LE. Genetic epidemiology of birth defects: nonsyndromic cleft lip and neural tube defects. Epidemiol Rev 1997; 19(l): 61–8
  • Mitchell LE, Christensen K. Analysis of the recurrence patterns for nonsyndromic cleft lip with or without cleft palate in the families of 3,073 Danish probands. Am J Med Genet 1996; 61 (4): 371–6
  • Tolarova M, Morton NE. Empirical recurrence risks in facial clefts. Acta Chir Plast 1975; 17(3): 97–112
  • Spence MA, Westlake J, Lange K, et al. Estimation of polygenic recurrence risk for cleft lip and palate. Hum Hered 1976; 26(5): 327–36

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.